FindTrial
Sign In

A study of antibody level in fully vaccinated individuals with covishield.

A kinetic study of anti-spike antibody titer amongst individuals vaccinated with two doses of covishield

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034222
Enrollment
60
Registered
2021-06-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Dr Hemangi Virani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have taken two doses of covishield vaccine and willing to participate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
antibody titreTimepoint: 1, 3, 6 and 9 months—

Secondary

MeasureTime frame
To compare antibody titre between previously infected and non-infected personsTimepoint: 1, 3, 6 and 9 months—

Countries

India

Contacts

Public ContactDr Hemangi Virani

Government Medical College ,Bhavnagar

hemangivirani124@gmail.com6355251050

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026